Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Natasha Hernday currently holds 15,500 shares of PDL BIOPHARMA, INC. (PDLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Natasha Hernday has been a net neutral trader of PDLI stock. They have purchased $0 and sold $0 worth of shares.
Natasha Hernday's most recent insider trade was on Jun 11, 2026, when they sold 15,500 shares at $0.00 per share.
Natasha Hernday serves as Executive at PDL BIOPHARMA, INC. (PDLI). They have executed 19 insider transactions totaling $0 over their tenure at the company.
Natasha Hernday holds the position of Executive at PDL BIOPHARMA, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Natasha Hernday has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Natasha Hernday was on Dec 15, 2020, when they purchased $100.0K worth of XOMA shares. This transaction involved 4,000 shares at $25.00 per share.
Natasha Hernday currently owns 15,500 shares of PDL BIOPHARMA, INC. (PDLI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Natasha Hernday's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Natasha Hernday has 19 Form 4 filings on record as an insider at PDL BIOPHARMA, INC..
Set alerts for Natasha Hernday and 40,000+ other insiders.